Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Net Margin (2022 - 2025)

Cardio Diagnostics Holdings' Net Margin history spans 4 years, with the latest figure at 60053.8% for Q3 2025.

  • For Q3 2025, Net Margin fell 3858623.0% year-over-year to 60053.8%; the TTM value through Sep 2025 reached 41516.33%, down 1839070.0%, while the annual FY2024 figure was 24028.24%, 2505957.0% up from the prior year.
  • Net Margin for Q3 2025 was 60053.8% at Cardio Diagnostics Holdings, down from 22517.71% in the prior quarter.
  • Across five years, Net Margin topped out at 16365.88% in Q2 2024 and bottomed at 250321.79% in Q4 2022.
  • The 4-year median for Net Margin is 26156.85% (2023), against an average of 80283.38%.
  • The largest annual shift saw Net Margin skyrocketed 22416493bps in 2023 before it tumbled -14780295bps in 2025.
  • A 4-year view of Net Margin shows it stood at 250321.79% in 2022, then surged by 90bps to 26156.85% in 2023, then decreased by -29bps to 33672.61% in 2024, then crashed by -78bps to 60053.8% in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Net Margin are 60053.8% (Q3 2025), 22517.71% (Q2 2025), and 173942.98% (Q1 2025).